Continuous Ambulatory Peritoneal Dialysis: A Review of its Mechanics,Advantages,Complications,and Areas of Controversy

Abstract

Spanish

French

OBJECTIVE:

The primary objective of this article is to review the mechanics, advantages, complications, pharmacokinetics, and future trends of continuous ambulatory peritoneal dialysis (CAPD) as they pertain to pharmacotherapy.

DATA SOURCES:

Pertinent articles were obtained from an English-language literature search using MEDLINE (1980–1991), Index Medicus (1987–1990), and bibliographic reviews of review articles. Indexing terms included peritoneal dialysis, pharmacokinetics, peritonitis, vancomycin, and fluoroquinolones.

DATA SYNTHESIS:

All clinical studies comparing organism recovery methods and treatment of peritonitis have methodologic limitations (e.g., comparison of disparate patient groups, different definitions of peritonitis, lack of follow-up, lack of control for sterile cultures) that may affect the reported results.

CONCLUSIONS:

CAPD is an alternative to hemodialysis for the treatment of endstage renal disease and has many complications, leading to significant morbidity. This indicates that CAPD is not appropriate for all patients. Using blood-culturing techniques to culture for dialysate is most productive, but also the most costly. There are few data to indicate exactly the drugs, doses, and durations of choice for peritonitis. Both intraperitoneal and oral administration appear to be appropriate.

Get full access to this article

View all access options for this article.

References

Ganter

. Uber die Beseitigung giftiger Stoffe aus dem Blute durch Dialyse. Muench Med Wochenschr 1923; 70: 1478–80.

Fine

Frank

Seligman

. The treatment of acute renal failure by peritoneal irrigation. Ann Surg 1946; 124: 857–75.

Popovich

Moncrief

Decherd

Bomar

Pyle

. The definition of a novel portable-wearable equilibrium peritoneal technique (abstract). Abst Am Soc Artif Intern Organs 1976; 64.

Oreopoulos

Robson

Izatt

Clayton

De Vener

. A safe and simple technique for continuous ambulatory peritoneal dialysis (CAPD). Trans Am Soc Artif Intern Organs 1978; 24: 484–9.

Nolph

. Continuous ambulatory peritoneal dialysis as long-term treatment for end-stage renal disease. Am J Kidney Dis 1991; 17: 154–7.

US Renal Data System. USRDS 1991 Annual Report. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, August 1991.

Heaton

Rodger

RSC

Sellars

Goodship

THJ

Fletcher

Nikolakis

. Continuous ambulatory peritoneal dialysis after the honeymoon: Review of experience in Newcastle 1979–84. Br Med J 1986; 293: 938–41.

Morgan

Burden

. Effects of continuous ambulatory peritoneal dialysis on a British renal unit. Br Med J 1986; 293: 935–7.

Pollock

Ibels

Caterson

Mahoney

Waugh

Cocksedge

. Continuous ambulatory peritoneal dialysis: Eight years experience at a single center. Medicine 1989; 68: 293–308.

10.

Segoloni

. A computer network for the registry of the Italian Multicenter Study Group on CAPD (abstract). Perit Dial Int 1991; 11 (suppl):244.

11.

Auer

Gokal

Stout

Hillier

Kincey

Simon

. The Oxford-Manchester study of dialysis patients. Age, risk factors and treatment method in relation to quality of life. Scand J Urol Nephrol 1990; 131 (suppl):31–7.

12.

Wilcox

Finch

Burdon

Morgan

. Peritonitis complicating continuous ambulatory peritoneal dialysis in Nottingham 1983–1988. J Med Microbiol 1991; 34: 137–41.

13.

Nolph

Twardowski

. The peritoneal dialysis system. In: Nolph

, ed. Peritoneal dialysis. Boston: Martinus Nijhoff, 1985: 23–50.

14.

Andrews

Porter

. The ultrastructural morphology and possible functional significance of mesothelial microvilli. Anal Rec 1974; 177: 409–26.

15.

Verbrugh

. The biology of the peritoneal membrane during chronic peritoneal dialysis. Adv Exp Med Biol 1989; 260: 129–33.

16.

Korthuis

Granger

. Role of the peritoneal microcirculation in peritoneal dialysis. In: Nolph

, ed. Peritoneal dialysis. 3rd ed. Boston: Kluwer Academic Publishers, 1989: 28–47.

17.

Nolph

. Lymphatic absorption during peritoneal dialysis. Adv Exp Med Biol 1989; 260: 135–8.

18.

Jaffrin

Odell

Farrell

. A model of ultrafiltration and glucose mass transfer kinetics in peritoneal dialysis. Artif Organs 1987; 11: 198–207.

19.

Pedersen

Dragsholt

Laier

Frifelt

Trostmann

Ekelund

. Alternate use of amino acid and glucose solutions in CAPD. Perit Dial Bull 1985;(Oct-Dec.):215–8.

20.

Young

Dibble

Hobson

Tompkins

Gibson

Turney

. The use of amino acid-based CAPD fluid over 12 weeks. Nephrol Dial Transplant 1989; 4: 285–92.

21.

Hanning

Balfe

Zlotkin

. Effectiveness and nutritional consequences of amino-acid versus glucose based dialysis solutions in infants and children receiving CAPD. Am J Clin Nutr 1987; 46: 22–30.

22.

Dombros

Prutis

Tong

Anderson

Harrison

Sombolos

. Six-month overnight intraperitoneal amino-acid infusion in continuous ambulatory peritoneal dialysis (CAPD) patients—no effect on nutritional status. Perit Dial Int 1990; 10: 79–84.

23.

Onwubalili

. Successful peritoneal dialysis using 0.9% sodium chloride with modified M/6 sodium lactate solution and recycled catheters. Nephron 1989; 53: 24–6.

24.

Morton

Roscoe

. Comparison of 35 and 40 mmolar lactate dialysate solutions during intermittent peritoneal dialysis (abstract). Perit Dial Int 1991; 11 (suppl):182.

25.

Feriani

La Greca

. CAPD with bicarbonate solution. Adv Exp Med Biol 1989; 260: 13947.

26.

Gross

Somani

Higgins

. A comparison of glucose polymer and dextrose containing dialysate in CAPD patients. Trans Am Soc Artif Intern Organs 1984; 30: 483–5.

27.

Maher

. Physiology of the peritoneum: Implications for peritoneal dialysis. Med Clin North Am 1990; 74: 985–96.

28.

Nolph

Twardowski

Keshaviah

. Weekly clearances of urea and creatinine on CAPD and NIPD. Perit Dial Int 1992; 12: 298–303.

29.

Keshaviah

Nolph

Van Stone

. The peak concentration hypothesis: A urea kinetic approach to comparing the adequacy of CAPD and hemodialysis. Perit Dial Int 1989; 9: 257–60.

30.

Sargent

Gotch

. The analysis of concentration-dependence of uremic lesions in clinical studies. Kidney Int 1975; 7 (suppl 2):S35–44.

31.

Barth

. Dialysis by the numbers: The false promise of Kt/V. Semin Dial 1989; 2: 207–12.

32.

Gotch

. Application of urea kinetic modeling to adequacy of CAPD therapy. Adv Perit Dial 1990; 6: 178–80.

33.

Teehan

Schleifer

Brown

Sigler

Raimondo

. Urea kinetic analysis and clinical outcome on CAPD. A five year longitudinal study. Adv Perit Dial 1990; 6: 181–5.

34.

Twardowski

. PET—a simple approach for determining prescriptions for adequate dialysis therapy. Adv Perit Dial 1990; 6: 186–91.

35.

Linblad

Novak

Nolph

Stablein

Cutler

. The 1987 USA National CAPD registry report. Trans Am Soc Artif Intern Organs 1988; 34: 150–6.

36.

Jensen

Davidson

Pomeroy

Cox

McMurray

. Evaluation of dressing protocols that reduce peritoneal dialysis catheter exit site infections. Am Nephrol Nurse Assoc J 1989; 16: 425–31.

37.

Piraino

. A review of Staphylococcus aureus exit site and tunnel infections in peritoneal dialysis patients. Am J Kidney Dis 1990; 16: 89–95.

38.

Bernardini

Holley

Johnston

Perlmutter

Piraino

. An analysis of ten-year trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 1991; 36: 29–34.

39.

Rubin

Adair

. Peritoneal access using the Tenckhoff catheter. Perspectives Perit Dial 1983; 1: 2–3.

40.

Mars

. Topical cefazolin solution to treat recalcitrant exit site infections (abstract). Perit Dial Int 1991; 11 (suppl):221.

41.

Koukoudis

Miserlis

Gakis

Kokolina-Simoglov

Belechri

Imviros

. Treatment of the exit site and tunnel infection in CAPD patients (abstract). Perit Dial Int 1991; 11 (suppl): 149.

42.

Scalamogna

Castelnovo

De Vecchi

Ponticelli

. Exit site and tunnel infections in CAPD (abstract). Perit Dial Int 1991; 11 (suppl): 233.

43.

Swartz

. Chronic peritoneal dialysis: Mechanical and infectious complications. Nephron 1985; 40: 29–37.

44.

Cloonan

Gatrell

Cushner

. Emergencies in continuous dialysis patients. Am J Emerg Med 1990; 8: 134–48.

45.

Keller

Reetze

Schollmeyer

. Drug therapy in patients undergoing continuous ambulatory peritoneal dialysis. Clinical pharmacokinetic considerations. Clin Pharmacokinet 1990; 18: 104–17.

46.

Paton

Cornish

Manuel

Hardy

. Drug therapy in patients undergoing peritoneal dialysis. Clinical pharmacokinetic considerations. Clin Pharmacokinet 1985; 10: 404–26.

47.

Bennet

. Guide to drug dosing in renal failure. Clin Pharmacokinet 1988; 15: 326–54.

48.

Jusko

Baliah

Kim

Gerbracht

Yaffe

. Pharmacokinetics of gentamicin during peritoneal dialysis in children. Kidney Int 1976; 9: 430–8.

49.

Saklayen

. CAPD peritonitis. Incidence, pathogens, diagnosis and management. Med Clin North Am 1990; 74: 997–1009.

50.

Keane

Everett

Fine

Golper

Vas

Peterson

. Continuous ambulatory peritoneal dialysis (CAPD) peritonitis treatment recommendations: 1989 update. Perit Dial Int 1989; 9: 247–56.

51.

Morse

Apicella

Walshe

. Absorption of intraperitoneal antibiotics. Drug Intell Clin Pharm 1988; 22: 58–61.

52.

Somani

Freimer

Gross

Higgins

. Pharmacokinetics of imipenem-cilastatin in patients with renal insufficiency undergoing continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 1988; 32: 530–4.

53.

Lameire

Ringoir

. Pharmacokinetic aspects of drug transport in continuous ambulatory peritoneal dialysis. Adv Exp Med Biol 1989; 260: 105–16.

54.

Bailie

Eisele

Veniezia

Yocum

Hollister

. Prediction of serum concentrations following intraperitoneal loading doses of vancomycin in CAPD patients with peritonitis. Clin Pharmacokinet 1992; 22: 298–307.

55.

Bastani

Spyker

Westervelt

. Peritoneal absorption of vancomycin during and after resolution of peritonitis in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1988; 8: 135–6.

56.

Peterson

Matzke

Keane

. Current concepts in the management of peritonitis in patients undergoing CAPD. Rev Infect Dis 1987; 9: 604–12.

57.

Rubin

Ray

Barnes

Teal

Hellems

Humphries

. Peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1983; 11: 602–7.

58.

Korzets

Golan

Zevin

Bernheim

. CAPD peritonitis presenting as an acute abdomen with a clear effluent (abstract). Perit Dial Int 1991; 11 (suppl):145.

59.

Pagniez

Delvallez

Reade

Dequiedt

. Cloudy effluent clearing after stopping ip antibiotics (abstract). Perit Dial Int 1991; 11 (suppl):199.

60.

Majorca

Cancarini

Colombrita

Manili

Camerini

. Further experience with Y-system in continuous ambulatory peritoneal dialysis. In: Khanna

Nolph

Prowant

Twardowski

Oreopoulos

, eds. Advances in CAPD. Toronto: University of Toronto Press, 1986: 172–5.

61.

Viglino

Colombo

Scalamogna

Cavalli

Guerra

Renzetti

. Prospective randomized study of two Y devices in CAPD. Perit Dial Int 1989; 9: 165–8.

62.

Vonesh

. Modeling peritonitis rates and associated risk factors for individuals on continuous ambulatory peritoneal dialysis. Stat Med 1990; 9: 263–71.

63.

Steinberg

Cutler

Novak

Nolph

. Report of the National CAPD Registry of the National Institutes of Health: characteristics of participants and selected outcome measures for the period January 1, 1981 through August 31, 1984. In: National CAPD Registry of the National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases. Washington, DC: US Public Health Service, 1985.

64.

Corey

. An approach to the statistical analysis of peritonitis data from patients on CAPD. Perit Dial Bull 1981; 1 (suppl):29–32.

65.

Ludlam

Barton

. Intraperitoneal treatment of CAPD peritonitis with ciprofloxacin. J Antimicrob Chemother 1989; 24: 621–2.

66.

Bint

Finch

Gokal

Goldsmith

Junor

Oliver

. Diagnosis and management of peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1987; 1: 845–8.

67.

Boyce

Wood

Thomson

Kerr

Atkins

. Intraperitoneal vancomycin therapy for CAPD peritonitis—a prospective, randomized comparison of intermittent v continuous therapy. Am J Kidney Dis 1988; 12: 304–6.

68.

Fenton

SSA

Bowman

Cattran

Manuel

Khanna

. The reduction in the peritonitis rate among high risk patients with the use of the Oreopoulos-Zellerman connector. Trans Am Soc Artif Intern Organs 1985; 31: 560–4.

69.

Gokal

Ramos

Francis

DMA

Ferner

Goodship

THJ

Proud

. Peritonitis in continuous ambulatory peritoneal dialysis: Laboratory and clinical studies. Lancet 1982; 2: 1388–91.

70.

Gould

Caswell

. The laboratory diagnosis of peritonitis during continuous ambulatory peritoneal dialysis. J Hosp Infect 1986; 7: 155–60.

71.

Chan

PCK

Cheng

IPK

Chan

WSF

. Pseudomonas peritonitis in CAPD patients: Characteristics and outcome of treatment. Nephrol Dial Transplant 1989; 4: 814–7.

72.

Brown

Hendler

. Rhodococcus peritonitis in a patient treated with peritoneal dialysis. Am J Kidney Dis 1989; 14: 417–8.

73.

Dressler

Peters

Lynn

. Pseudomonal and candidal peritonitis as a complication of continuous ambulatory peritoneal dialysis in human immunodeficiency virus infected patients. Am J Med 1989; 86: 787–90.

74.

London

Damsker

Neibart

Knorr

Bottone

. Mycobacterium gordonae: An unusual bacterial pathogen in a patient undergoing continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1988; 85: 703–4.

75.

Merlin

Tzamaloukas

. Mycobacterium chelonae peritonitis associated with continuous ambulatory peritoneal dialysis. Am J Clin Pathol 1989; 91: 717–20.

76.

Polo

Luno

Menarguez

Gallego

Rables

Hernandez

. Peritoneal mucormycosis in a patient receiving continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1989; 13: 237–9.

77.

Mallat

Brensilver

. Tuberculous peritonitis in a CAPD patient cured without catheter removal: Case report, review of the literature, and guidelines for treatment and diagnosis. Am J Kidney Dis 1989; 13: 154–7.

78.

Kerr

Perfect

Craven

Jorgensen

Drutz

Shelburne

. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann Intern Med 1983; 99: 334–7.

79.

Eisenberg

Leviton

Soeiro

. Fungal peritonitis in patients receiving peritoneal dialysis: Experience with 11 patients and review of the literature. Rev Infect Dis 1986; 8: 309–21.

80.

Cheng

IPK

Fang

Chan

PCK

Chan

. Fungal peritonitis complicating peritoneal dialysis: Report of 27 cases and review of treatment. Q J Med 1989; 71: 407–16.

81.

Sombolos

Vas

Rifkin

Ayiomamitis

McNamee

Oreopoulos

. Propionibacteria isolates and asymptomatic infections of the peritoneal effluent in CAPD patients. Nephrol Dial Transplant 1986; 1: 175–8.

82.

Von Graevenitz

. Is there an optimal methodology for the microbiological analysis of effluent in CAPD peritonitis? Zentralbl Bakteriol Mikrobiol Hyg A 1988; 267: 331–8.

83.

Rubin

. Continuous ambulatory peritoneal dialysis: Dialysate fluid cultures. Clin Microbiol Newsl 1984; 6: 3–5.

84.

Vas

. Microbiological aspects of peritonitis. Perit Dial Bull 1981; 1: 11–6.

85.

Vas

Law

. Microbiological diagnosis of peritonitis in patients on continuous ambulatory peritoneal dialysis. J Clin Microbiol 1985; 21: 522–3.

86.

Goupal

Cordy

. Bacterial isolation from peritoneal fluids in CAPD patients. Can J Med Technol 1984; 46: 186–8.

87.

Males

Walshe

Amsterdam

. Laboratory indices of clinical peritonitis: Total leukocyte count, microscopy, and microbiologic culture of peritoneal dialysis effluent. J Clin Microbiol 1987; 25: 2367–71.

88.

Ryan

Fessia

. Improved method for recovery of peritonitis-causing microorganisms from peritoneal dialysate. J Clin Microbiol 1987; 25: 383–4.

89.

Morton

Roberts

Keaney

MGL

Ganguli

Waldek

Holmes

. Reduction in culture-negative CAPD peritonitis using the BACTEC system (abstract 113). Perit Dial Int 1988;8th annual CAPD abstracts.

90.

Saubolle

Holland

Jenkins

. Efficacy of 9 methods for the microbiologic evaluation of dialysis effluent from patients on CAPD (abstract C-10). Perit Dial Int 1988;abstracts of the annual meeting: 333.

91.

Holley

Moss

. A prospective evaluation of blood culture versus standard plate techniques for diagnosing peritonitis in CAPD. Am J Kidney Dis 1989; 13: 184–8.

92.

Stokley

Kwan

JTC

Bending

Chin

ATL

Eisinger

. Isolation of organisms in CAPD peritonitis: Use of nutrient broth cultures and Bactec blood culture media. J Hosp Infect 1988; 11: 77–81.

93.

Rayner

Williams

Oliver

. Direct inoculation of peritoneal fluid into Bactec blood culture bottles improves positive microbiological culture rate in CAPD patients with suspected peritonitis (abstract). Perit Dial Int 1991; 11: 219.

94.

Forbes

Frymoyer

Kopecky

Wojtaszek

Pettit

. Evaluation of the lysis centrifugation system for culturing dialysates from CAPD patients with peritonitis. Am J Kidney Dis 1988; 11: 176–9.

95.

Nakamoto

Goya

Kazama

Ishiodori

. Comparison of culture methods for microorganisms in CAPD peritonitis (abstract). Perit Dial Int 1991; 11 (suppl):185.

96.

MacDonald

Watts

Bowmer

. Factors affecting Staphylococcus epidermidis growth in peritoneal dialysis solutions. J Clin Microbiol 1986; 24: 104–7.

97.

Verbrugh

Keane

Conroy

Peterson

. Bacterial growth and killing in CAPD fluids. J Clin Microbiol 1984; 20: 199–203.

98.

Bailie

Rasmussen

Figge

Eisele

. Peritonitis rates using O-set and UVXD systems (abstract 12). Perit Dial Int 1991; 11.

99.

Moncrief

Rutherford

Sorrels

PAJ

Bailey

Popovich

. Technical aspects of CAPD new connection devices developed by Baxter Travenol Laboratories. In: Legrain

, ed. Proceedings of the First International Symposium on CAPD. Amsterdam: Excerpta Medica, 1980: 79–81.

100.

Nolph

. Complications during CAPD. In: Legrain

, ed. Proceedings of the First International Symposium on CAPD. Amsterdam: Excerpta Medica, 1980: 258–62.

101.

Mavichak

Moriarty

Cameron

Reeve

Ballon

Lauener

. Three and a half years experience with CAPD using the Beta-cap technique. Trans Am Soc Artif Intern Organs 1982; 28: 253–8.

102.

Di Paolo

Buoncristiani

Frigato

De Mia

Rubengni

. A new system for CAPD. In: Gahl

Kessel

Nolph

, eds. Proceedings of the Second International Symposium on Peritoneal Dialysis. Amsterdam: Excerpta Medica, 1981: 105–10.

103.

Nolph

Prowant

Serke

. A randomized, multi-centre clinical trial to evaluate the effects of an ultraviolet germicidal system on peritonitis rate in CAPD. Perit Dial Bull 1985; 5: 19–24.

104.

Swartz

Reynolds

Lees

Rocher

. Disconnect during CAPD: Retrospective experience with three different systems. Perit Dial Int 1989; 9: 175–8.

105.

Buoncristiani

. The Y set with disinfectant is here to stay (abstract). Perit Dial Int 1989; 9: 149.

106.

Maiorca

Cancarini

Brasa

. Y-system with disinfectant in the prevention of peritonitis in CAPD. Contr Nephrol 1987; 57: 178–84.

107.

Spenier

. Infections in continuous ambulatory peritoneal dialysis. J Med Microbiol 1988; 27: 1–9.

108.

Horton

Deeter

Sherman

. Treatment of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Clin Pharm 1990; 9: 102–18.

109.

Favre

Probst

. Pharmacokinetics of ceftriaxone after intravenous administration to CAPD patients with and without peritonitis. Chemotherapeutica 1987; (suppl 2):273–4.

110.

Fuiano

Sepe

Viscione

Nani

Conte

. Effectiveness of single daily intraperitoneal administration of aztreonam and cefuroxime in the treatment of peritonitis in CAPD. Perit Dial Int 1989; 9: 273–5.

111.

Leehey

Reid

Chan

Ing

. Cefoperazone in the treatment of peritonitis in CAPD patients. Artif Organs 1988; 12: 482–3.

112.

Ludlam

Dryden

Barton

Phillips

. Short course ciprofloxacin therapy for CAPD peritonitis. J Antimicrob Chemother 1990; 26: 162–4.

113.

Ludlam

Barton

White

McMullin

King

Phillips

. Intraperitoneal ciprofloxacin for the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis. J Antimicrob Chemother 1990; 25: 843–51.

114.

Fleming

Phillips

Stewart

Scott

. Oral ciprofloxacin in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis. J Antimicrob Chemother 1990; 25: 441–8.

115.

Dharmasena

Roberts

Coles

Williams

. Pharmacokinetics of intraperitoneal ciprofloxacin in patients on CAPD. J Antimicrob Chemother 1989; 23: 253–9.

116.

Passlick

Wonner

Keller

Essers

Grabensee

. Single and multiple dose kinetics of ofloxacin in patients on CAPD. Perit Dial Int 1989; 9: 267–72.

117.

Rose

Ellis-Pegler

Collins

Small

. Oral pefloxacin mesylate in the treatment of continuous ambulatory peritoneal dialysis associated peritonitis: An open non-comparative study. J Antimicrob Chemother 1990; 25: 853–9.

118.

Rose

Bremner

Collins

Ellis-Pegler

Isaacs

Richardson

. Plasma and dialysate levels of pefloxacin and its metabolites in CAPD patients with peritonitis. J Antimicrob Chemother 1990; 25: 657–64.

119.

Dratwa

Glupczynski

Lameire

Matthys

Verschraegen

Vaneeckhoute

. Aztreonam in CAPD peritonitis. Lancet 1987; 2: 213–4.

120.

Brown

Altmann

Cummingham

Shaw

Marsh

. Pharmacokinetics of once daily intraperitoneal aztreonam and vancomycin in the treatment of CAPD peritonitis. J Antimicrob Chemother 1990; 25: 141–7.

121.

Dratwa

Glupczynski

Lameire

Matthys

Verschraegen

Vaneechoutte

. Treatment of gram-negative peritonitis with aztreonam in patients undergoing continuous ambulatory peritoneal dialysis. Rev Infect Dis 1991; 13 (suppl 7):S645–7.

122.

Churchill

Taylor

Vas

Singer

Beecroft

. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients: A randomized clinical trial of co-trimoxazole prophylaxis. Perit Dial Int 1988; 8: 125–8.

123.

Magera

Arroyo

Rosansky

Postic

. Vancomycin pharmacokinetics in patients with peritonitis on peritoneal dialysis. Antimicrob Agents Chemother 1983; 23: 710–4.

124.

Hernandez

Jurado

Montoya

. Use of vancomycin infusion in the treatment of uncomplicated peritonitis in a peritoneal dialysis population to reduce cost (abstract). Perit Dial Bull 1986; 6 (suppl):S10.

125.

Bastani

Freer

Read

Bailey

Sherman

Davis

. Treatment of gram-positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis. Nephron 1987; 45: 283–5.

126.

Bailie

Morton

Ganguli

Keaney

Waldek

. Intravenous or intraperitoneal vancomycin for the treatment of continuous ambulatory peritoneal dialysis associated gram-positive peritonitis. Nephron 1987; 46: 316–8.

127.

Harford

Sica

Tartaglione

Polk

Dalton

Poynor

. Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis. Nephron 1986; 43: 217–22.

128.

Morse

Farolino

Apicella

Walshe

. Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 1987; 31: 171–7.

129.

Milliken

Matzke

Keane

. Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1991; 11: 252–60.

130.

Suga

Tanaka

Kato

Nakazato

Suzuki

Honda

. Intravenous administration of antibiotics for CAPD peritonitis (abstract). Perit Dial Int 1991; 11 (suppl):261.

131.

Domoto

Gallagher

Blalock

Ballal

. Efficacy of streptokinase in slow to resolve peritonitis (abstract). Perit Dial Int 1991; 11 (suppl):70.

132.

Pickering

Fleming

Bowley

Sissons

Oppenheim

Burnie

. Urokinase: A treatment for relapsing peritonitis due to coagulase-negative staphylococci. Nephrol Dial Transplant 1989; 4: 62–5.

133.

Norris

Shinaberger

Reyes

Kraut

. The use of intracatheter instillation of streptokinase in the treatment of recurrent bacterial peritonitis in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1987; 10: 62–5.

134.

Mawhinney

Adair

Gorman

. Development and treatment of peritonitis in continuous ambulatory peritoneal dialysis. Int J Pharm Pract 1991; 1: 10–8.

135.

Paton

Reeves

. Fluoroquinolone antibiotics. Drugs 1988; 36: 193–228.

136.

Terp

Rybak

. Ciprofloxacin. Drug Intell Clin Pharm 1987; 21: 568–74.

137.

Sanders

. Ciprofloxacin: In-vitro activity, mechanism of action, and resistance. Rev Infect Dis 1988; 10: 516–25.

138.

Frieden

Mangi

. Inappropriate use of oral ciprofloxacin. JAMA 1990; 264: 1438–40.

139.

Barriere

. Economic impact of oral ciprofloxacin. Am J Med 1987; 72 (suppl 4A):387–90.

140.

Guay

DRP

. Oral fluoroquinolone versus mono- or combination parenteral therapy in the management of bacterial infections: A critical appraisal. DICP Ann Pharmacother 1990; 24: 11–8.

141.

Le Pennec

Kitzis

Terdjman

Foubard

Garbarz

Hanania

. Possible interaction of ciprofloxacin with ferrous sulphate. J Antimicrob Chemother 1990; 25: 184–5.

142.

Garrelts

Godley

Peterie

Gerlach

Yakshe

. Sucralfate significantly reduces ciprofloxacin concentrations in serum. Antimicrob Agents Chemother 1990; 34: 931–3.

143.

Van Slooten

Nix

Wilton

Love

Spivey

Goldstein

. Combined use of ciprofloxacin and sucralfate. DICP Ann Pharmacother 1991; 25: 578–82.

144.

Flor

Guay

DRP

Opsahl

Tack

Matzke

. Effects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacin. Antimicrob Agents Chemother 1990; 34: 2436–8.

145.

Polk

Healy

Sahai

Drwal

Racht

. Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers. Antimicrob Agents Chemother 1989; 33: 1841–4.

146.

Lomaestro

Bailie

. Effect of staggered dose of calcium on the bioavailability of ciprofloxacin. Antimicrob Agents Chemother 1991; 35: 1004–7.

147.

Bunke

Aronoff

Brier

Sloan

Luft

. Vancomycin kinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther 1983; 34: 631–7.

148.

Blevins

Halstenson

Salem

Matzke

. Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 1984; 25: 603–6.

149.

Rogge

Johnson

Zimmerman

Welling

. Vancomycin disposition during continuous ambulatory peritoneal dialysis: A pharmacokinetic analysis of peritoneal drug transport. Antimicrob Agents Chemother 1985; 27: 578–82.

150.

Bailie

Eisele

Venezia

Yocum

Hollister

. Prediction of serum vancomycin concentrations following intra-peritoneal loading doses in continuous ambulatory peritoneal dialysis patients with peritonitis. Clin Pharmacokinet 1992; 22: 298–307.

151.

Pancorbo

Comty

. Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis. Nephron 1982; 31: 37–9.

152.

Ball

Fox

Ball

Brown

Willis

. Pharmacokinetics of oral ciprofloxacin, 100 mg single dose, in volunteers and elderly patients. J Antimicrob Chemother 1986; 17: 629–35.

153.

Webb

Roberts

Williams

Asscher

. Pharmacokinetics of ciprofloxacin in healthy volunteers and patients with impaired kidney function. J Antimicrob Chemother 1986; 18 (suppl D):83–7.

154.

Shalit

Greenwood

Marks

Pederson

Frederick

. Pharmacokinetics of single-dose oral ciprofloxacin in patients undergoing chronic ambulatory peritoneal dialysis. Antimicrob Agents Chemother 1986; 30: 152–6.

155.

Kowalsky

Echols

Schwartz

Bailie

McCormick

. Pharmacokinetics of ciprofloxacin in subjects with varying degrees of renal function and undergoing hemodialysis or CAPD. Clin Nephrol 1992 (in press).

156.

Friedland

Iveson

Fraise

Winnearls

Selkon

Oliver

. A comparison between intraperitoneal ciprofloxacin and intraperitoneal vancomycin and gentamicin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD). J Antimicrob Chemother 1990; 26 (suppl F):77–81.

157.

Bennett-Jones

Russell

Barrett

. A comparison between oral ciprofloxacin and intraperitoneal vancomycin and gentamicin in the treatment of CAPD peritonitis. J Antimicrob Chemother 1990; 26 (suppl F):73–6.

158.

Tapson

Orr

George

Stansfield

Bint

Ward

. A comparison between oral ciprofloxacin and intraperitoneal vancomycin and netilmicin in CAPD peritonitis. J Antimicrob Chemother 1990; 26 (suppl F):63–71.

159.

Paladino

Sperry

Backes

Gelber

Serrianne

Cumbo

. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics. Am J Med 1991; 91: 462–70.

160.

Kay

Bailie

Bernstein

. Patient knowledge of cardio-respiratory drugs. J Clin Pharm Ther 1988; 13: 263–8.

161.

Bailie

Kay

. Patients' knowledge of sublingual glyceryl trinitrate. Br Med J 1988; 297: 32.

162.

Horsley

Bailie

. Risk factors for inadequate use of pressurized aerosol inhalers. J Clin Pharm Ther 1988; 13: 139–43.

163.

Blanchard

Berger

Bailie

Eisele

. Knowledge of hemodialysis and CAPD patients about their prescribed medicines. Clin Nephrol 1990; 34: 173–8.

164.

Weed-Collins

Hogan

. Knowledge and health beliefs regarding phosphate-binding medication in predicting compliance. Am Nephrol Nurse Assoc J 1989; 16: 278–86.

165.

Skoutakis

Acchiardo

Martinez

Lorisch

Wood

. Role effectiveness of the pharmacist in the treatment of hemodialysis patients. Am J Hosp Pharm 1978; 35: 62–5.

166.

Federal Register. Infectious waste management, docket num;F-88-IWMA-FFFFF 53; 106, June 2. 1988.20140–3.

167.

Guidelines for handwashing and environmental control—infective waste. Atlanta: Centers for Disease Control, 1985: 15–6.

168.

Hedrick

. Infectious waste management—will science prevail? Infect Control Hosp Epidemiol 1988; 9: 488–90.

169.

Council on Scientific Affairs. Infectious medical wastes. JAMA 1989; 262: 669–71.

170.

Marcus

. HIV antibody in chronic hemodialysis patients. United States. Abstracts of 5th International Conference on AIDS, Montreal, June 4–9, 1989, T.A.P. 27.

171.

Favero

. Increase in the reported number of HIV-infected patients in U.S. dialysis centers from 1985 to 1987. Abstracts of 5th International Conference on AIDS, Montreal, June 4–9, 1989, T.A.P. 26.

172.

Van Beers

Dratwa

Sprecher

Schils

Smet

. Peritoneal dialysis in AIDS: Another risky situation? In: Khanna

Nolph

, eds. Advances in continuous ambulatory peritoneal dialysis. Toronto: University of Toronto Press, 1988: 133–7.

173.

Correa-Rotter

Saldivar

Soto

De Leon

Ponce S

Ojeda

Ruiz-Palacios

. Recovery of HIV antigen in peritoneal dialysis fluid. Perit Dial Int 1990; 10: 67–9.

174.

Williams

Swan

Cunningham

. Continuous ambulatory peritoneal fluid: Another fluid positive for HIV antibody (letter). Br Med J 1986; 293: 885.

175.

Koger

. Peritoneal dialysis in HIV positive patients. Am Nephrol Nurse Assoc J 1988; 15: 47–8.

176.

Rutala

Odette

Samsa

. Management of infectious waste by US hospitals. JAMA 1989; 262: 1635–40.

177.

Storage, treatment and disposal of infectious waste. Title 15, article 27 of Environmental Conservation Law, State of New York, Feb 19, 1987.

178.

Bailie

Kowalsky

Eisele

Schwartzman

. Disposal of CAPD waste in the community. Perit Dial Int 1991; 11: 72–5.

179.

Vas

. Environmental protection and peritoneal dialysis garbage. Perit Dial lnt 1991; 11: 12–3.

180.

Oreopoulos

. Peritoneal dialysis research for the 1990s. Perit Dial Int 1992; 12: 278–80.

181.

Homes

Aldous

. Stability of miconazole in peritoneal dialysis fluid. Am J Hosp Pharm 1991; 48: 286–90.

182.

Homes

Aldous

. Stability of co-trimoxazole in peritoneal dialysis fluid. Perit Dial Int 1990; 10: 157–60.

183.

Drake

Myre

Staneck

Draeger

. Antimicrobial activity of vancomycin, gentamicin and tobramycin in peritoneal dialysis solution. Am J Hosp Pharm 1990; 47: 1604–6.

184.

Nahata

. Stability of ceftriaxone sodium in peritoneal dialysis solutions. DICP Ann Pharmacother 1991; 25: 741–2.

185.

Paap

Nahata

. Stability of cefotaxime in two peritoneal dialysis solutions. Am J Hosp Pharm 1990; 47: 147–50.

186.

Mawhinney

Adair

Gorman

McClurg

. Long-term stability of teicoplanin in dialysis fluid: Implications for the home-treatment of CAPD peritonitis. Int J Pharm Pract 1991; 1: 90–3.

187.

Mai

Emmett

Sheikh

Ana

Santa CA

Schiller

. Calcium acetate, an effective phosphorus binder in patients with renal failure. Kidney Int 1989; 36: 690–5.

188.

Delmez

Slatopolsky

. Hyperphosphatemia: Its consequences and treatment in patients with chronic renal disease. Am J Kidney Dis 1992; 19: 303–17.